PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.45%
Positive revenue growth while 1113.HK is negative. John Neff might see a notable competitive edge here.
12.25%
Positive gross profit growth while 1113.HK is negative. John Neff would see a clear operational edge over the competitor.
-89.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-530.70%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-106.93%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-107.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-107.36%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-3.79%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-5.94%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
80.89%
OCF growth under 50% of 1113.HK's 228.73%. Michael Burry might suspect questionable revenue recognition or rising costs.
89.37%
FCF growth 50-75% of 1113.HK's 162.60%. Martin Whitman would see if structural disadvantages exist in generating free cash.
40423.24%
10Y revenue/share CAGR above 1.5x 1113.HK's 194.53%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
257.50%
Positive 5Y CAGR while 1113.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
32.25%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
228.03%
10Y OCF/share CAGR 1.25-1.5x 1113.HK's 169.97%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
314.45%
5Y OCF/share CAGR above 1.5x 1113.HK's 23.99%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-18.70%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
90.46%
Net income/share CAGR above 1.5x 1113.HK's 5.70% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-145.65%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-104.66%
Negative 3Y CAGR while 1113.HK is 97.50%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
3.96%
Below 50% of 1113.HK's 1782.74%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
14.95%
5Y equity/share CAGR at 75-90% of 1113.HK's 19.85%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
4.89%
Below 50% of 1113.HK's 13.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.17%
We show growth while 1113.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.51%
Negative asset growth while 1113.HK invests at 0.97%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.49%
We have a declining book value while 1113.HK shows 1.70%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-12.81%
We’re deleveraging while 1113.HK stands at 9.23%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
19.23%
SG&A growth well above 1113.HK's 11.58%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.